Provenance Wealth Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$94.3K Buy
227
+48
+27% +$17.8K 0.01% 187
2026
Q1
$48.4K Sell
179
-63
-26% -$18.8K 0.01% 204
2025
Q4
$79.9K Hold
242
0.01% 171
2025
Q3
$83.6K Buy
242
+173
+251% +$52.3K 0.01% 176
2025
Q2
$21.5K Sell
69
-794
-92% -$303K ﹤0.01% 258
2025
Q1
$452K Sell
863
-1,768
-67% -$904K 0.07% 73
2024
Q4
$1.33M Buy
2,631
+2,080
+377% +$1.18M 0.17% 36
2024
Q3
$322K Sell
551
-13
-2% -$7.35K 0.04% 122
2024
Q2
$287K Sell
564
-33
-6% -$16.2K 0.04% 118
2024
Q1
$295K Sell
597
-15
-2% -$7.63K 0.04% 118
2023
Q4
$322K Buy
612
+112
+22% +$59.7K 0.04% 107
2023
Q3
$252K Buy
+500
New +$246K 0.04% 105

Other funds holding UNH

Provenance Wealth Advisors's UNH Position: Q2 2026 in Review

Provenance Wealth Advisors increased its UnitedHealth (UNH) stake by 27% in Q2 2026, buying an estimated $17.8K and bringing the position to 227 shares worth $94.3K. The position accounts for 0.01% of the portfolio, ranked #187.

Provenance Wealth Advisors first reported a position in UNH in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.33M in Q4 2024. 1,733 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Provenance Wealth Advisors held 227 shares of UnitedHealth worth $94.3K as of Q2 2026.
  • Provenance Wealth Advisors bought 48 UnitedHealth shares in Q2 2026, an estimated $17.8K.
  • UnitedHealth made up 0.01% of Provenance Wealth Advisors's portfolio in Q2 2026, its #187 holding.
  • Provenance Wealth Advisors first reported a position in UnitedHealth in Q3 2023 and has held it in 12 quarters since.
  • Provenance Wealth Advisors's UnitedHealth position peaked at $1.33M in Q4 2024.
  • 1,733 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Provenance Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.